138
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Association of lipoprotein subfractions with endothelial function and arterial stiffness in acute ischemic stroke

, , , , , , & show all
Pages 36-39 | Received 05 Apr 2016, Accepted 27 Sep 2016, Published online: 19 Oct 2016

References

  • Kwiterovich PO Jr. Lipoprotein heterogeneity: diagnostic and therapeutic implications. Am J Cardiol 2002;90:1–10.
  • Castelli WP. The new pathophysiology of coronary artery disease. Am J Cardiol 1998;82:60–5.
  • Oravec S, Gruber K, Dostal E, Mikl J. Hyper-betalipoproteinemia LDL 1,2: a newly identified nonatherogenic hypercholesterolemia in a group of hypercholesterolemic subjects. Neuro Endocrinol Lett 2011;32:322–7.
  • Van J, Pan J, Charles MA, Krauss R, Wong N, Wu X. Atherogenic lipid phenotype in a general group of subjects. Arch Pathol Lab Med 2007;131:1679–85.
  • Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, Mitchell GF, Sheffy J, Vita JA, Benjamin EJ. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008;117:2467–74.
  • Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168–75.
  • Patvardhan E, Heffernan KS, Ruan J, Hession M, Warner P, Karas RH, Kuvin JT. Augmentation index derived from peripheral arterial tonometry correlates with cardiovascular risk factors. Cardiol Res Pract 2011;2011:253758.
  • Brott T, Adams H, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864–70.
  • Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999;30:1538–41.
  • Hoefner DM, Hodel SD, O’Brien JF, Branum EL, Sun D, Meissner I, McConnell JP. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 2001;47:266–74.
  • Oravec S, Dukat A, Gavornik P, Lovasova Z, Gruber K. Atherogenic normolipidemia: a new phenomenon in the lipoprotein profile of clinically healthy subjects. Neuro Endocrinol Lett 2011;32:317–21.
  • Siarnik P, Carnicka Z, Krizova L, Wagnerova H, Sutovsky S, Klobucnikova K, Kollar B, Turcani P, Sykora M. Predictors of impaired endothelial function in obstructive sleep apnea syndrome. Neuro Endocrinol Lett 2014;35:142–8.
  • Oravec S, Dukat A, Gavornik P, Caprdna M, Kucera M. Serum lipoprotein profile in newly recognized arterial hypertension. The role of atherogenic lipoproteins in the pathogenesis of disease. Vnitr Lek 2010;56:967–71.
  • Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002;43:1363–79.
  • Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans 2003;31:1066–9.
  • Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, Schaefer EJ. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 2004;24:2181–7.
  • Oravec S, Dostal E, Dukat A, Gavornik P, Kucera M, Gruber K. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia. Neuro Endocrinol Lett 2011;32:502–9.
  • Oravec S, Dukat A, Gavornik P, Caprnda M, Kucera M, Ocadlik I. Contribution of the atherogenic lipoprotein profile to the development of arterial hypertension. Bratisl Lek Listy 2011;112:4–7.
  • Oravec S, Krivosikova Z, Krivosik M, Gruber K, Gruber M, Dukat A, Gavornik P. Lipoprotein profile in patients who survive a stroke. Neuro Endocrinol Lett 2011;32:496–501.
  • Vishnu A, Choo J, Masaki KH, Mackey RH, Barinas-Mitchell E, Shin C, Willcox BJ, El-Saed A, Seto TB, Fujiyoshi A, Miura K. Particle numbers of lipoprotein subclasses and arterial stiffness among middle-aged men from the ERA JUMP study. J Hum Hypertens 2014;28:111–7.
  • Ding C, Hsu SH, Wu YJ, Su TC. Additive effects of postchallenge hyperglycemia and low-density lipoprotein particles on the risk of arterial stiffness in healthy adults. Lipids Health Dis 2014;13:179.
  • Okumura K, Takahashi R, Taguchi N, Suzuki M, Cheng XW, Numaguchi Y, Ikeda N, Murohara T. Small low-density lipoprotein cholesterol concentration is a determinant of endothelial dysfunction by peripheral artery tonometry in men. J Atheroscler Thromb 2012;19:897–903.
  • Weber T, Auer J, O’Rourke MF, Kvas E, Lassnig E, Lamm G, Stark N, Rammer M, Eber B. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J 2005;26:2657–63.
  • Weber T, O’Rourke MF, Lassnig E, Porodko M, Ammer M, Rammer M, Eber B. Pulse waveform characteristics predict cardiovascular events and mortality in patients undergoing coronary angiography. J Hypertens 2010;28:797–805.
  • Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, Pumper GM, Lerman LO, Lerman A. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010;31:1142–8.
  • Heffernan KS, Patvardhan EA, Kapur NK, Karas RH, Kuvin JT. Peripheral augmentation index as a biomarker of vascular aging: an invasive hemodynamics approach. Eur J Appl Physiol 2012;112:2871–9.
  • Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588–605.
  • London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001;38:434–8.
  • O’Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens Suppl 1996;14:147–57.
  • Moerland M, Kales AJ, Schrier L, van Dongen MG, Bradnock D, Burggraaf J. Evaluation of the EndoPAT as a Tool to Assess Endothelial Function. Int J Vasc Med 2012;2012:904141
  • Yan B, Parsons M, McKay S, Campbell D, Infeld B, Czajko R, Davis SM. When to measure lipid profile after stroke? Cerebrovasc Dis 2005;19:234–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.